Effect of rhGH treatment on biochemical growth markers
IGF-1 SDS, IGF-1/IGFBP-3 molar ratio, and serum IGFBP-3 increased from baseline to week 39 and remained stable until the end of the study. At week 52, ΔIGF-1 SDS (3.52 ± 1.64, 